NDT-EDUCATIONAL

September 2014

  • Including accessory arteries in renal denervation found to be more successful

    Renal denervation seems to be more successful at reducing blood pressure in patients with resistant hypertension when it includes accessory renal arteries, according to research presented at ESC Congress by Dr Linda Schmiedel from Germany.

  • Building replacement kidneys in the lab

    Regenerative medicine researchers at Wake Forest Baptist Medical Center have addressed a major challenge in the quest to build replacement kidneys in the lab. Working with human-sized pig kidneys, the scientists developed the most successful method to date to keep blood vessels in the new organs open and flowing with blood. The work is reported in journal Technology.

  • Hypertension may be initiated by an autoimmune response

    High blood pressure is a major risk factor for heart attack, stroke, chronic heart failure, and kidney disease. Inflammation is thought to promote the development of high blood pressure, though it is not clear what triggers inflammatory pathways in hypertension.

  • Diabetes gene discovered in mice and men

    A joint work by EPFL, ETH Zurich and the CHUV has identified a pathological process that takes place in both mice and humans towards one of the most common diseases that people face in the industrialized world: type 2 diabetes.

  • Invasive kidney biopsy for lupus patients may be replaced by math model

    Mathematics might be able to reduce the need for invasive biopsies in patients suffering kidney damage related to the autoimmune disease lupus.

  • Plant-derived compound 'may effectively treat lupus with fewer side effects'

    There is no cure for lupus, but there are medications that can help manage its symptoms. However, some of these drugs cause side effects and increase the risk of other health problems. Now, researchers from the University of Houston, TX, say they have discovered a more natural treatment for the disease that uses a plant extract.

  • Transplant recipients infected with BK virus at increased risk of rejection

    Kidney transplant recipients infected with BK virus are more likely to develop antibodies against their kidney transplants than uninfected patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).